Skip to content
Menu
Wicked Sister
Wicked Sister

Category: Multiple Sclerosis Research

ECTRIMS STATS

Posted on January 16, 2026 by

Tweet So neuros are invited to learn about statistics. So whilst they are off to Naples to learn, as you tuck into your frozen pizza (it’s almost Naples after all) you too can learn some statistics which will help to determine how much you log-in to your memory banks that will help you to read…

+

New online fitness program targets US veterans with MS, mobility issues

Posted on January 15, 2026 by

Paralyzed Veterans of America (PVA) — a congressionally chartered veterans organization open to all military service members with multiple sclerosis (MS) — has launched a new, free, online fitness and wellness program that offers adaptive, expert-led classes for individuals with mobility challenges. The initiative is designed specifically for veterans living with diseases such as MS,…

+

Living with MS makes me a lot like Scarlett, our pet corn snake

Posted on January 15, 2026 by

I wrote a few years ago about a snake we kept that temporarily went missing. It was a wild snake that we released back into the wild because that was the right thing to do. The kids were quite taken with it, however, so we obtained a captive-raised corn snake to keep as a pet,…

+

EBV can trick the immune system to attack myelin in at-risk individuals

Posted on January 15, 2026 by

A history of the Epstein-Barr virus (EBV) appears to alter the immune systems of people with specific genetic traits, causing their own cells to mistakenly flag brain proteins as dangerous threats, according to a new study. This discovery offers insight into how these risk factors — viral infection and genetics — interact to contribute to…

+

Cinder’s Ugly Sister gets her foot in the Shoe or Is it trail blazing?

Posted on January 15, 2026 by

Tweet Thomas et al. Anoctamin-2-specific T cells link Epstein-Barrvirus to multiple sclerosis. Cell (2026), https://doi.org/10.1016/j.cell.2025.12.032 Epstein-Barr virus (EBV) infection constitutes a prerequisite for multiple sclerosis (MS) development, and cross-reactivity between EBV nuclear antigen 1 (EBNA1) and anoctamin-2 (ANO2) antibodies was previously demonstrated in persons with MS (pwMS). Here, we show that ANO2-specific CD4+ T cells…

+

Risk of MS among women drops by over 40% with greater vitamin D intake

Posted on January 14, 2026 by

A greater intake of vitamin D, from both food and supplements, was linked to a 42% lower risk of developing multiple sclerosis (MS) among women living in Norway, according to a large prospective study. “Our findings suggest that a higher dietary intake of vitamin D decreases the risk of developing MS,” the researchers wrote, noting…

+

Learning to be intentional about my relationship with food

Posted on January 14, 2026 by

For a long time, food was simply a necessity — something I grabbed between classes, appointments, or bouts of fatigue. I didn’t think much about how it made me feel, aside from the noticeable energy dips or sugar highs. Living with multiple sclerosis (MS) has gradually shifted my perspective, though. Over time, I’ve realized that…

+

Top 10 MS news stories of 2025

Posted on January 14, 2026 by

Throughout 2025, the team at Multiple Sclerosis News Today brought readers the latest advances and updates in research related to multiple sclerosis (MS). Here are the top 10 most-read news stories MSNT published this year. Source: irelandms.com

+

Making Plans on Your Terms

Posted on January 14, 2026 by

By Angel Blair I always considered myself a planner. I constantly made lists; I carefully thought out decisions, big or small, to get to the most optimal outcome. I loved comparing the pros and cons of possibilities for things to … Continue reading → Source: blog.mymsaa.org

+

Find gets new funding for treatment to repair damaged myelin

Posted on January 14, 2026 by

Find Therapeutics has secured CA$10 million (approximately $7.4 million) in funding to continue advancing tasronetide, its lead candidate for boosting myelin repair in people with multiple sclerosis (MS). The Series A extension financing round follows the completion of a Phase 1 trial in healthy volunteers, in which tasronetide was deemed safe and well tolerated. The…

+
  • Previous
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 86
  • Next

Recent Posts

  • Me-Too Natalizumab…. Does Holland have the West London Feeling?
  • I trusted my gut, even after hearing I was ‘too young’ to have MS
  • I regained the confidence to travel after my MS diagnosis
  • The Crap Gap with Natalizumab..No clues
  • Common anti-aging drugs may damage brain’s protective coating

Recent Comments

    Archives

    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • September 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • May 2022
    • February 2022
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • July 2019

    Categories

    • Multiple Sclerosis Research
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    NAVBAR

    Archive 1

    MS Search

    Recent

      ©2026 Wicked Sister | Powered by Superb Themes